Search research articles
Contact Us
Filters
Showing results (1-10 of 229) with videos related to
Page
of 23
Sort By:
Cell Stem Cell
|
June 24, 2010
Metastatic cancer stem cells: an opportunity for improving cancer treatment?
Maximilian Diehn, Ravindra Majeti
Annual Review of Pathology
|
November 24, 2020
Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA
Jonathan C Dudley, Maximilian Diehn
Journal of the National Cancer Institute
|
December 21, 2006
Cancer stem cells and radiotherapy: new insights into tumor radioresistance
Maximilian Diehn, Michael F Clarke
Lancet (London, England)
|
April 16, 2019
SABR-COMET: harbinger of a new cancer treatment paradigm
Billy W Loo, Maximilian Diehn
Seminars in Radiation Oncology
|
March 16, 2015
Molecular determinants of radiation response in non-small cell lung cancer
Sue S Yom, Maximilian Diehn, David Raben
Seminars in Radiation Oncology
|
March 16, 2015
To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer
David Benjamin Shultz, Maximilian Diehn, Billy W Loo
Cell
|
October 16, 2010
The Myc connection: ES cells and cancer
Michael E Rothenberg, Michael F Clarke, Maximilian Diehn
JAMA Oncology
|
July 9, 2017
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li, Yi Cui, Maximilian Diehn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 14, 2010
Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer
J Martin Brown, Maximilian Diehn, Billy W Loo
Seminars in Radiation Oncology
|
March 3, 2009
Therapeutic implications of the cancer stem cell hypothesis
Maximilian Diehn, Robert W Cho, Michael F Clarke
Page
of 23
Search research articles
Search
Showing results (1-10 of 229) with videos related to
Sort By:
Page
of 23
Cell Stem Cell
|
June 24, 2010
Metastatic cancer stem cells: an opportunity for improving cancer treatment?
Maximilian Diehn, Ravindra Majeti
Annual Review of Pathology
|
November 24, 2020
Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA
Jonathan C Dudley, Maximilian Diehn
Journal of the National Cancer Institute
|
December 21, 2006
Cancer stem cells and radiotherapy: new insights into tumor radioresistance
Maximilian Diehn, Michael F Clarke
Lancet (London, England)
|
April 16, 2019
SABR-COMET: harbinger of a new cancer treatment paradigm
Billy W Loo, Maximilian Diehn
Seminars in Radiation Oncology
|
March 16, 2015
Molecular determinants of radiation response in non-small cell lung cancer
Sue S Yom, Maximilian Diehn, David Raben
Seminars in Radiation Oncology
|
March 16, 2015
To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer
David Benjamin Shultz, Maximilian Diehn, Billy W Loo
Cell
|
October 16, 2010
The Myc connection: ES cells and cancer
Michael E Rothenberg, Michael F Clarke, Maximilian Diehn
JAMA Oncology
|
July 9, 2017
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li, Yi Cui, Maximilian Diehn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 14, 2010
Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer
J Martin Brown, Maximilian Diehn, Billy W Loo
Seminars in Radiation Oncology
|
March 3, 2009
Therapeutic implications of the cancer stem cell hypothesis
Maximilian Diehn, Robert W Cho, Michael F Clarke
Page
of 23